Mi-Hua Tao

Title: Mi-Hua Tao: Innovator in Allergy Treatment

Introduction

Mi-Hua Tao is a notable inventor based in Hsien, Taiwan. He has made significant contributions to the field of allergy treatment through his innovative research and development of recombinant eukaryotic plasmids. With a total of two patents to his name, Tao's work focuses on the prevention and treatment of allergic diseases.

Latest Patents

Mi-Hua Tao's latest patents include "Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases." This invention relates to recombinant eukaryotic plasmids that comprise an eukaryotic expression vector and an allergen gene. When administered to individuals in need of prevention or treatment, the recombinant vector can inhibit the production of allergen-specific IgE synthesis. The invention also encompasses pharmaceutical compositions that utilize the recombinant vector for the prevention and treatment of allergic diseases.

Career Highlights

Throughout his career, Mi-Hua Tao has worked with various companies, including Jen Wen Co., Ltd. His expertise in the field has allowed him to develop groundbreaking solutions for allergy management.

Collaborations

Mi-Hua Tao has collaborated with notable individuals in his field, including Ching-Hsiang Hsu and Kaw-Yan Chua. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Mi-Hua Tao's innovative work in the field of allergy treatment through recombinant eukaryotic plasmids showcases his dedication to improving health outcomes for individuals suffering from allergic diseases. His contributions are significant and continue to impact the medical community positively.